Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Dosage Form
     • Market Snippet, By Indication
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Opportunities
   • Key Highlights
   • Regulatory Scenario
   • Recent Trends
   • Product Launches/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Mergers, Acquisitions, and Collaborations
4. Global Nifedipine Medication Market – Impact of Coronavirus (COVID-19) Pandemic
   • COVID-19 Epidemiology
   • Supply Side and Demand Side Analysis
   • Economic Impact
5. Global Nifedipine Medication Market, By Dosage Form, 2018-2030, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 - 2030
     • Segment Trends
   • Tablets
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
   • Extended-Release Tablets
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
   • Capsules
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
   • Others (Sublingual tablets/spray, Patches and Others)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
6. Global Nifedipine Medication Market, By Indication, 2018-2030, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 - 2030
     • Segment Trends
   • Hypertension
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
   • Angina Pectoris
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
   • Raynaud's Phenomenon
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
   • Others (Pre-term labor, vasospastic conditions and Others)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
7. Global Nifedipine Medication Market, By Distribution Channel, 2018-2030, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 - 2030
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
8. 8. Global Nifedipine Medication Market, By Region, 2018-2030, (US$ Mn)
   • Introduction
     • Market Share Analysis, By Sub-region, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, For Sub-region, 2019 –2030
     • Segment Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
       • U.S.
       • Canada
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
       • Brazil
       • Argentina
       • Mexico
       • Rest of Latin America
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
       • Germany
       • U.K.
       • Spain
       • France
       • Italy
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Mn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Mn)
       • South Africa
       • North Africa
       • Central Africa
9. Competitive Landscape
   • Company Profile
     • Pfizer Inc
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Novartis AG
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Merck & Co., Inc.
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • AstraZeneca PLC
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Teva Pharmaceutical Industries Ltd
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Mylan N.V.
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Sanofi S.A.
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Johnson & Johnson
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • GlaxoSmithKline plc.
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Lupin Limited
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Sun Pharmaceutical Industries Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Sandoz International GmbH (a Novartis division)
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Dr. Reddy's Laboratories Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Torrent Pharmaceuticals Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Apotex Inc.
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Analyst Views
10. Section
    • References
    • Research Methodology
    • About us

*Browse 35 market data tables and 33 figures on "Global Nifedipine Medication Market” – Global forecast to 2030